Autoimmune Diseases in Patients with Premature Ovarian Insufficiency-Our Current State of Knowledge

Anna Szeliga, Anna Calik-Ksepka, Marzena Maciejewska-Jeske, Monika Grymowicz, Katarzyna Smolarczyk, Anna Kostrzak, Roman Smolarczyk, Ewa Rudnicka, Blazej Meczekalski, Anna Szeliga, Anna Calik-Ksepka, Marzena Maciejewska-Jeske, Monika Grymowicz, Katarzyna Smolarczyk, Anna Kostrzak, Roman Smolarczyk, Ewa Rudnicka, Blazej Meczekalski

Abstract

Premature ovarian insufficiency (POI), previously known as premature ovarian failure or premature menopause, is defined as loss of ovarian function before the age of 40 years. The risk of POI before the age of 40 is 1%. Clinical symptoms develop as a result of estrogen deficiency and may include amenorrhea, oligomenorrhea, vasomotor instability (hot flushes, night sweats), sleep disturbances, vulvovaginal atrophy, altered urinary frequency, dyspareunia, low libido, and lack of energy. Most causes of POI remain undefined, however, it is estimated that anywhere from 4-30% of cases are autoimmune in origin. As the ovaries are a common target for autoimmune attacks, an autoimmune etiology of POI should always be considered, especially in the presence of anti-oocyte antibodies (AOAs), autoimmune diseases, or lymphocytic oophoritis in biopsy. POI can occur in isolation, but is often associated with other autoimmune conditions. Concordant thyroid disorders such as hypothyroidism, Hashimoto thyroiditis, and Grave's disease are most commonly seen. Adrenal autoimmune disorders are the second most common disorders associated with POI. Among women with diabetes mellitus, POI develops in roughly 2.5%. Additionally, autoimmune-related POI can also present as part of autoimmune polyglandular syndrome (APS), a condition in which autoimmune activity causes specific endocrine organ damage. In its most common presentation (type-3), APS is associated with Hashomoto's type thyroid antibodies and has a prevalence of 10-40%. 21OH-Antibodies in Addison's disease (AD) can develop in association to APS-2.

Keywords: APS; Hashimoto disease; POI; autoimmune.

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Webber L., Davies M., Anderson R., Bartlett J., Braat D., Cartwright B., Cifkova R., Keizer-Schrama S.D.M., Hogervorst E., Janse F., et al. ESHRE Guideline: Management of women with premature ovarian insufficiency. Hum. Reprod. 2016;31:926–937. doi: 10.1093/humrep/dew027.
    1. Faubion S.S., Kuhle C.L., Shuster L.T., Rocca W.A. Long-term health consequences of premature or early menopause and considerations for management. Climacteric. 2015;18:483–491. doi: 10.3109/13697137.2015.1020484.
    1. Luisi S., Orlandini C., Regini C., Pizzo A., Vellucci F., Petraglia F. Premature ovarian insufficiency: From pathogenesis to clinical management. J. Endocrinol. Investig. 2015;38:597–603. doi: 10.1007/s40618-014-0231-1.
    1. Domniz N., Meirow D. Premature ovarian insufficiency and autoimmune diseases. Best Pr. Res. Clin. Obstet. Gynaecol. 2019;60:42–55. doi: 10.1016/j.bpobgyn.2019.07.008.
    1. Luborsky J., Meyer P., Sowers M., Gold E., Santoro N. Premature menopause in a multi-ethnic population study of the menopause transition. Hum. Reprod. 2003;18:199–206. doi: 10.1093/humrep/deg005.
    1. Jiao X., Zhang H., Ke H., Zhang J., Cheng L., Liu Y., Qin Y., Chen Z.-J. Premature Ovarian Insufficiency: Phenotypic Characterization within Different Etiologies. J. Clin. Endocrinol. Metab. 2017;102:2281–2290. doi: 10.1210/jc.2016-3960.
    1. Laven J.S.E. Primary Ovarian Insufficiency. Semin. Reprod. Med. 2016;34:230–234. doi: 10.1055/s-0036-1585402.
    1. Rossetti R., Ferrari I., Bonomi M., Persani L. Genetics of primary ovarian insufficiency. Clin. Genet. 2017;91:183–198. doi: 10.1111/cge.12921.
    1. Reindollar R.H. Turner Syndrome: Contemporary Thoughts and Reproductive Issues. Semin. Reprod. Med. 2011;29:342–352. doi: 10.1055/s-0031-1280919.
    1. Kirshenbaum M., Orvieto R. Premature ovarian insufficiency (POI) and autoimmunity-an update appraisal. J. Assist. Reprod. Genet. 2019;36:2207–2215. doi: 10.1007/s10815-019-01572-0.
    1. Sharif K., Watad A., Bridgewood C., Kanduc D., Amital H., Shoenfeld Y. Insights into the autoimmune aspect of premature ovarian insufficiency. Best Pr. Res. Clin. Endocrinol. Metab. 2019;33:101323. doi: 10.1016/j.beem.2019.101323.
    1. Collins G., Patel B., Thakore S., Liu J. Primary Ovarian Insufficiency: Current Concepts. South. Med. J. 2017;110:147–153. doi: 10.14423/SMJ.0000000000000611.
    1. Gargus E., Deans R., Anazodo A., Woodruff T.K. Management of Primary Ovarian Insufficiency Symptoms in Survivors of Childhood and Adolescent Cancer. J. Natl. Compr. Cancer Netw. 2018;16:1137–1149. doi: 10.6004/jnccn.2018.7023.
    1. Vabre P., Gatimel N., Moreau J., Gayrard V., Picard-Hagen N., Parinaud J., Léandri R. Environmental pollutants, a possible etiology for premature ovarian insufficiency: A narrative review of animal and human data. Environ. Health. 2017;16:1–18. doi: 10.1186/s12940-017-0242-4.
    1. Kobayashi M., Nakashima A., Yoshino O., Yoshie M., Ushijima A., Ito M., Ono Y., Shima T., Kawamura K., Ishizuka B., et al. Decreased effector regulatory T cells and increased activated CD4+ T cells in premature ovarian insufficiency. Am. J. Reprod. Immunol. 2019;81:e13125. doi: 10.1111/aji.13125.
    1. Sedmak D.D., Hart W.R., Tubbs R.R. Autoimmune oophoritis: A histopathologic study of involved ovaries with immunologic characterization of the mononuclear cell infiltrate—PubMed. [(accessed on 6 October 2020)];Int. J. Gynecol. Pathol. 1987 6:73–81. doi: 10.1097/00004347-198703000-00009. Available online:
    1. Irvine W.J. Thyroid Auto-Immunity as a Disorder of Immunological Tolerance. Q. J. Exp. Physiol. Cogn. Med. Sci. 1964;49:324–337. doi: 10.1113/expphysiol.1964.sp001738.
    1. Ebrahimi M., Akbari A.F. The role of autoimmunity in premature ovarian failure—PubMed. [(accessed on 23 January 2021)];Iran. J. Reprod. Med. 2015 13:461–472. Available online:
    1. Xiong J., Tan R., Wang W., Wang H., Pu D., Wu J. Evaluation of CD4+CD25+FOXP3+ regulatory T cells and FOXP3 mRNA in premature ovarian insufficiency. Climacteric. 2020;23:267–272. doi: 10.1080/13697137.2019.1703938.
    1. Hoek A., Schoemaker J., Drexhage H.A. Premature Ovarian Failure and Ovarian Autoimmunity*. Endocr. Rev. 1997;18:107–134. doi: 10.1210/edrv.18.1.0291.
    1. Silva C.A., Yamakami L.Y.S., Aikawa N.E., Araujo D.B., Carvalho J.F., Bonfá E. Autoimmune primary ovarian insufficiency. Autoimmun. Rev. 2014;13:427–430. doi: 10.1016/j.autrev.2014.01.003.
    1. Komorowska B. Autoimmune premature ovarian failure. Menopausal Rev. 2016;4:210–214. doi: 10.5114/pm.2016.65666.
    1. Pra C.D., Chen S., Furmaniak J., Smith B.R., Pedini B., Moscon A., Zanchetta R., Betterle C. Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison’s disease. Eur. J. Endocrinol. 2003;148:565–570. doi: 10.1530/eje.0.1480565.
    1. Bakalov V., Vanderhoof V., Bondy C., Nelson L. Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. Hum. Reprod. 2002;17:2096–2100. doi: 10.1093/humrep/17.8.2096.
    1. Saglam F., Onal E.D., Ersoy R., Koca C., Ergin M., Erel O., Cakir B. Anti-Müllerian hormone as a marker of premature ovarian aging in autoimmune thyroid disease. Gynecol. Endocrinol. 2014;31:165–168. doi: 10.3109/09513590.2014.973391.
    1. Magen E., Masalha A., Zueva E., Vardy D.A. Possible Autoimmune Primary Ovarian Insufficiency in Patients with Selective IgA Deficiency. Isr. Med. Assoc. J. IMAJ. 2018;20:192–193.
    1. Tang V.W., Faiman C. Premature ovarian failure: A search for circulating factors against gonadotropin receptors. Am. J. Obstet. Gynecol. 1983;146:816–821. doi: 10.1016/0002-9378(83)91084-0.
    1. De Bellis A., Bellastella G., Falorni A., Aitella E., Barrasso M., Maiorino M.I., Bizzarro E., Bellastella A., Giugliano D., Esposito K. Natural history of autoimmune primary ovarian insufficiency in patients with Addison’s disease: From normal ovarian function to overt ovarian dysfunction. Eur. J. Endocrinol. 2017;177:329–337. doi: 10.1530/EJE-17-0152.
    1. Luborsky J. Ovarian Autoimmune Disease and Ovarian Autoantibodies. J. Women’s Heal. Gender-Based Med. 2002;11:585–599. doi: 10.1089/152460902760360540.
    1. Novosad J.A., Kalantaridou S.N., Tong Z.-B., Nelson L.M. Ovarian antibodies as detected by indirect immunofluorescence are unreliable in the diagnosis of autoimmune premature ovarian failure: A controlled evaluation. BMC Women’s Health. 2003;3:2. doi: 10.1186/1472-6874-3-2.
    1. Akawatcharangura P., Taechakraichana N., Osiri M. Prevalence of premature ovarian failure in systemic lupus erythematosus patients treated with immunosuppressive agents in Thailand. Lupus. 2015;25:436–444. doi: 10.1177/0961203315617539.
    1. Mayorga J., Alpízar-Rodríguez D., Prieto-Padilla J., Romero-Díaz J., Cravioto M.C. Prevalence of premature ovarian failure in patients with systemic lupus erythematosus. Lupus. 2016;25:675–683. doi: 10.1177/0961203315622824.
    1. Gong L., Ji H.-H., Tang X.-W., Pan L.-Y., Chen X., Jia Y.-T. Human papillomavirus vaccine-associated premature ovarian insufficiency and related adverse events: Data mining of Vaccine Adverse Event Reporting System. Sci. Rep. 2020;10:1–8. doi: 10.1038/s41598-020-67668-1.
    1. Naleway A.L., Mittendorf K.F., Irving S.A., Henninger M.L., Crane B., Smith N., Daley M.F., Gee J. Primary Ovarian Insufficiency and Adolescent Vaccination. Pediatrics. 2018;142:e20180943. doi: 10.1542/peds.2018-0943.
    1. Ruehsen M.D.M., Blizzard R.M., Garcia-Bunuel R., Jones G.S. Autoimmunity and ovarian failure. Am. J. Obstet. Gynecol. 1972;112:693–703. doi: 10.1016/0002-9378(72)90797-1.
    1. Grossmann B., Saur S., Rall K., Pecher A.-C., Hübner S., Henes J., Henes M. Prevalence of autoimmune disease in women with premature ovarian failure. Eur. J. Contracept. Reprod. Health Care. 2019;25:72–75. doi: 10.1080/13625187.2019.1702638.
    1. Osuka S., Iwase A., Goto M., Takikawa S., Nakamura T., Murase T., Kato N., Kotani T., Kikkawa F. Bayasula Thyroid Autoantibodies do not Impair the Ovarian Reserve in Euthyroid Infertile Women: A Cross-Sectional Study. Horm. Metab. Res. 2018;50:537–542. doi: 10.1055/a-0637-9430.
    1. Betterle C., Rossi A., Pria S.D., Artifoni A., Pedini B., Gavasso S., Caretto A. Premature ovarian failure: Autoimmunity and natural history. Clin. Endocrinol. 1993;39:35–43. doi: 10.1111/j.1365-2265.1993.tb01748.x.
    1. Goswami R., Marwaha R.K., Goswami D., Gupta N., Ray D., Tomar N., Singh S. Prevalence of Thyroid Autoimmunity in Sporadic Idiopathic Hypoparathyroidism in Comparison to Type 1 Diabetes and Premature Ovarian Failure. J. Clin. Endocrinol. Metab. 2006;91:4256–4259. doi: 10.1210/jc.2006-1005.
    1. Hollowell J.G., Staehling N.W., Flanders W.D., Hannon W.H., Gunter E.W., Spencer C.A., Braverman L.E. Serum TSH, T4, and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III) J. Clin. Endocrinol. Metab. 2002;87:489–499. doi: 10.1210/jcem.87.2.8182.
    1. Reato G., Morlin L., Chen S., Furmaniak J., Smith B.R., Masiero S., Albergoni M.P., Cervato S., Zanchetta R., Betterle C. Premature Ovarian Failure in Patients with Autoimmune Addison’s Disease: Clinical, Genetic, and Immunological Evaluation. J. Clin. Endocrinol. Metab. 2011;96:E1255–E1261. doi: 10.1210/jc.2011-0414.
    1. La Marca A., Brozzetti A., Sighinolfi G., Marzotti S., Volpe A., Falorni A. Primary ovarian insufficiency: Autoimmune causes. Curr. Opin. Obstet. Gynecol. 2010;22:277–282. doi: 10.1097/GCO.0b013e32833b6c70.
    1. Forges T., Monnier-Barbarino P., Faure G.C., Bene M.C. Autoimmunity and antigenic targets in ovarian pathology. Hum. Reprod. Updat. 2004;10:163–175. doi: 10.1093/humupd/dmh014.
    1. Welt C.K. Autoimmune Oophoritis in the Adolescent. Ann. N. Y. Acad. Sci. 2008;1135:118–122. doi: 10.1196/annals.1429.006.
    1. Lewiński A., Ewa Płaczkiewicz-Jankowska E. Internal Medicine. Medycyna Praktyczna; Kraków, Poland: 2019. APS-III.
    1. Szlendak-Sauer K., Jakubik D., Kunicki M., Skórska J., Smolarczyk R. Autoimmune polyglandular syndrome type 3 (APS-3) among patients with premature ovarian insufficiency (POI) Eur. J. Obstet. Gynecol. Reprod. Biol. 2016;203:61–65. doi: 10.1016/j.ejogrb.2016.05.023.
    1. Kumar N., Manesh I. Premature Ovarian Insufficiency: Aetiology and Long-Term Consequences. Women’s Health Open J. 2017;3:45–58. doi: 10.17140/WHOJ-3-121.
    1. Ebrahimi M., Asbagh F.A. Pathogenesis and Causes of Premature Ovarian Failure: An Update. Int. J. Fertil. Steril. 2011;5:54–65.
    1. Bano G., Mansour S., Nussey S. The association of primary hyperparathyroidism and primary ovarian failure: A de novo t(X; 2) (q22p13) reciprocal translocation. Eur. J. Endocrinol. 2008;158:261–263. doi: 10.1530/EJE-07-0604.
    1. Podfigurna-Stopa A., Czyzyk A., Grymowicz M., Smolarczyk R., Katulski K., Czajkowski K., Meczekalski B. Premature ovarian insufficiency: The context of long-term effects. J. Endocrinol. Investig. 2016;39:983–990. doi: 10.1007/s40618-016-0467-z.
    1. Kulaksizoglu M., Ipekci S.H., Kebapcilar L., Kebapcilar A.G., Korkmaz H., Akyurek F., Baldane S., Gonen M.S. Risk Factors for Diabetes Mellitus in Women with Primary Ovarian Insufficiency. Biol. Trace Element Res. 2013;154:313–320. doi: 10.1007/s12011-013-9738-0.
    1. Gunning M.N., Meun C., Van Rijn B.B., Maas A.H.E.M., Benschop L., Franx A., Boersma E., Budde R.P.J., Appelman Y., Lambalk C.B., et al. Coronary artery calcification in middle-aged women with premature ovarian insufficiency. Clin. Endocrinol. 2019;91:314–322. doi: 10.1111/cen.14003.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅